Market Overview

UPDATE: Mizuho Securities USA Initiates Coverage On NewLink Genetics Corp On Emerging Market Pure Play


In a report published Friday, Mizuho Securities USA analyst Peter Lawson initiated coverage on NewLink Genetics Corp (NASDAQ: NLNK) with a Buy rating and $50.00 price target.

In the report, Mizuho Securities USA noted, “We are initiating coverage of shares of NewLink Genetics with a Buy rating and a price target of $50. NewLink is a pure play on the rapidly emerging immuno-oncology market, with substantial near-term catalysts that start 1Q15, a pipeline of 7 therapeutics across multiple settings using both small molecule and biological drugs and two late Phase III trials.”

NewLink Genetics Corp closed on Thursday at $26.68.

Latest Ratings for NLNK

Feb 2019MaintainsNeutralNeutral
Jan 2019DowngradesNeutralUnderperform
Nov 2018MaintainsNeutralNeutral

View More Analyst Ratings for NLNK
View the Latest Analyst Ratings

Posted-In: Mizuho Securities USA Peter LawsonAnalyst Color Initiation Analyst Ratings


Related Articles (NLNK)

View Comments and Join the Discussion!

Latest Ratings

View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Morning Market Movers

UPDATE: Wunderlich Initiates Coverage On Perry Ellis International, Inc.